Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
NECTIN-4 [a poliovirus receptor-related-4 (pvrl-4) encoded protein] is a Ca2+ independent immunoglobulin-like protein. Along with other Nectins (Nectin-1, -2 and -3), it is primarily involved in cell-cell adhesion. In contrast to other Nectins, Nectin-4 is specifically enriched in the embryonic and...
Gespeichert in:
| Veröffentlicht in: | European journal of pharmacology 2021-11, Vol.911, p.174516, Article 174516 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 174516 |
| container_title | European journal of pharmacology |
| container_volume | 911 |
| creator | Chatterjee, Subhajit Sinha, Saptarshi Kundu, Chanakya Nath |
| description | NECTIN-4 [a poliovirus receptor-related-4 (pvrl-4) encoded protein] is a Ca2+ independent immunoglobulin-like protein. Along with other Nectins (Nectin-1, -2 and -3), it is primarily involved in cell-cell adhesion. In contrast to other Nectins, Nectin-4 is specifically enriched in the embryonic and placental tissues but its expression significantly declines in adult life. In recent years, it has been found that Nectin-4 is especially overexpressed and served as a tumor associated inducer in various malignant tumors including breast, lung, colorectal, pancreatic, ovarian cancers etc. Over-expression of Nectin-4 is associated with various aspects of tumor progression like proliferation, angiogenesis, epithelial to mesenchymal transition, metastasis, DNA repair, tumor relapse, poor prognosis in several types of cancer. This review systematically highlights the implications of Nectin-4 in every possible aspect of cancer and the molecular mechanism of Nectin-4 mediated cancer progression. We have further emphasized on the therapeutic strategies that are being proposed to specifically target Nectin-4. |
| doi_str_mv | 10.1016/j.ejphar.2021.174516 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2575370794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299921006701</els_id><sourcerecordid>2575370794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-1fa18a5342bdc46436886bdd730f8b9685113589cf25a7da045858b5d982888b3</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMozvj4ByJZ6qJjkiZN4kKQwRfIiDCuQ5rcOhk6bU06gv_eDlWXru7mO_dwPoTOKJlRQour9QzW3crGGSOMzqjkghZ7aEqV1BmRlO2jKSGUZ0xrPUFHKa0JIUIzcYgmORdcMl5M0esCXB8a7KCusfUrSKFt8KatwW1ryDi-WNzNl0-LjF9e41vctT00fbA17m18hx5XbcTONg4i7lcQbfd1gg4qWyc4_bnH6O3-bjl_zJ5fHp7mt8-ZywvWZ7SyVFmRc1Z6xwueF0oVpfcyJ5UqdaEEpblQ2lVMWOkt4UIJVQqvFVNKlfkxuhj_drH92ELqzSak3QzbQLtNhgkpckmk5gPKR9TFNqUIleli2Nj4ZSgxO5lmbUaZZifTjDKH2PlPw7bcgP8L_dobgJsRgGHnZ4BokgswyPAhDlqNb8P_Dd9Id4Ri</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2575370794</pqid></control><display><type>article</type><title>Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Chatterjee, Subhajit ; Sinha, Saptarshi ; Kundu, Chanakya Nath</creator><creatorcontrib>Chatterjee, Subhajit ; Sinha, Saptarshi ; Kundu, Chanakya Nath</creatorcontrib><description>NECTIN-4 [a poliovirus receptor-related-4 (pvrl-4) encoded protein] is a Ca2+ independent immunoglobulin-like protein. Along with other Nectins (Nectin-1, -2 and -3), it is primarily involved in cell-cell adhesion. In contrast to other Nectins, Nectin-4 is specifically enriched in the embryonic and placental tissues but its expression significantly declines in adult life. In recent years, it has been found that Nectin-4 is especially overexpressed and served as a tumor associated inducer in various malignant tumors including breast, lung, colorectal, pancreatic, ovarian cancers etc. Over-expression of Nectin-4 is associated with various aspects of tumor progression like proliferation, angiogenesis, epithelial to mesenchymal transition, metastasis, DNA repair, tumor relapse, poor prognosis in several types of cancer. This review systematically highlights the implications of Nectin-4 in every possible aspect of cancer and the molecular mechanism of Nectin-4 mediated cancer progression. We have further emphasized on the therapeutic strategies that are being proposed to specifically target Nectin-4.</description><identifier>ISSN: 0014-2999</identifier><identifier>ISSN: 1879-0712</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2021.174516</identifier><identifier>PMID: 34547246</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Angiogenesis ; Animals ; Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Cancer ; Cancer stemness ; Cell Adhesion Molecules - metabolism ; Humans ; Metastasis ; Molecular Targeted Therapy ; Nectin-4 ; Nectins ; Neoplasms - drug therapy ; Neoplasms - metabolism ; Neoplasms - pathology ; Therapeutic strategies</subject><ispartof>European journal of pharmacology, 2021-11, Vol.911, p.174516, Article 174516</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-1fa18a5342bdc46436886bdd730f8b9685113589cf25a7da045858b5d982888b3</citedby><cites>FETCH-LOGICAL-c362t-1fa18a5342bdc46436886bdd730f8b9685113589cf25a7da045858b5d982888b3</cites><orcidid>0000-0003-0297-1030 ; 0000-0003-0687-924X ; 0000-0001-9015-4473</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejphar.2021.174516$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34547246$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chatterjee, Subhajit</creatorcontrib><creatorcontrib>Sinha, Saptarshi</creatorcontrib><creatorcontrib>Kundu, Chanakya Nath</creatorcontrib><title>Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>NECTIN-4 [a poliovirus receptor-related-4 (pvrl-4) encoded protein] is a Ca2+ independent immunoglobulin-like protein. Along with other Nectins (Nectin-1, -2 and -3), it is primarily involved in cell-cell adhesion. In contrast to other Nectins, Nectin-4 is specifically enriched in the embryonic and placental tissues but its expression significantly declines in adult life. In recent years, it has been found that Nectin-4 is especially overexpressed and served as a tumor associated inducer in various malignant tumors including breast, lung, colorectal, pancreatic, ovarian cancers etc. Over-expression of Nectin-4 is associated with various aspects of tumor progression like proliferation, angiogenesis, epithelial to mesenchymal transition, metastasis, DNA repair, tumor relapse, poor prognosis in several types of cancer. This review systematically highlights the implications of Nectin-4 in every possible aspect of cancer and the molecular mechanism of Nectin-4 mediated cancer progression. We have further emphasized on the therapeutic strategies that are being proposed to specifically target Nectin-4.</description><subject>Angiogenesis</subject><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Cancer</subject><subject>Cancer stemness</subject><subject>Cell Adhesion Molecules - metabolism</subject><subject>Humans</subject><subject>Metastasis</subject><subject>Molecular Targeted Therapy</subject><subject>Nectin-4</subject><subject>Nectins</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Therapeutic strategies</subject><issn>0014-2999</issn><issn>1879-0712</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLxDAUhYMozvj4ByJZ6qJjkiZN4kKQwRfIiDCuQ5rcOhk6bU06gv_eDlWXru7mO_dwPoTOKJlRQour9QzW3crGGSOMzqjkghZ7aEqV1BmRlO2jKSGUZ0xrPUFHKa0JIUIzcYgmORdcMl5M0esCXB8a7KCusfUrSKFt8KatwW1ryDi-WNzNl0-LjF9e41vctT00fbA17m18hx5XbcTONg4i7lcQbfd1gg4qWyc4_bnH6O3-bjl_zJ5fHp7mt8-ZywvWZ7SyVFmRc1Z6xwueF0oVpfcyJ5UqdaEEpblQ2lVMWOkt4UIJVQqvFVNKlfkxuhj_drH92ELqzSak3QzbQLtNhgkpckmk5gPKR9TFNqUIleli2Nj4ZSgxO5lmbUaZZifTjDKH2PlPw7bcgP8L_dobgJsRgGHnZ4BokgswyPAhDlqNb8P_Dd9Id4Ri</recordid><startdate>20211115</startdate><enddate>20211115</enddate><creator>Chatterjee, Subhajit</creator><creator>Sinha, Saptarshi</creator><creator>Kundu, Chanakya Nath</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0297-1030</orcidid><orcidid>https://orcid.org/0000-0003-0687-924X</orcidid><orcidid>https://orcid.org/0000-0001-9015-4473</orcidid></search><sort><creationdate>20211115</creationdate><title>Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy</title><author>Chatterjee, Subhajit ; Sinha, Saptarshi ; Kundu, Chanakya Nath</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-1fa18a5342bdc46436886bdd730f8b9685113589cf25a7da045858b5d982888b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Angiogenesis</topic><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Cancer</topic><topic>Cancer stemness</topic><topic>Cell Adhesion Molecules - metabolism</topic><topic>Humans</topic><topic>Metastasis</topic><topic>Molecular Targeted Therapy</topic><topic>Nectin-4</topic><topic>Nectins</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Therapeutic strategies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chatterjee, Subhajit</creatorcontrib><creatorcontrib>Sinha, Saptarshi</creatorcontrib><creatorcontrib>Kundu, Chanakya Nath</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chatterjee, Subhajit</au><au>Sinha, Saptarshi</au><au>Kundu, Chanakya Nath</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2021-11-15</date><risdate>2021</risdate><volume>911</volume><spage>174516</spage><pages>174516-</pages><artnum>174516</artnum><issn>0014-2999</issn><issn>1879-0712</issn><eissn>1879-0712</eissn><abstract>NECTIN-4 [a poliovirus receptor-related-4 (pvrl-4) encoded protein] is a Ca2+ independent immunoglobulin-like protein. Along with other Nectins (Nectin-1, -2 and -3), it is primarily involved in cell-cell adhesion. In contrast to other Nectins, Nectin-4 is specifically enriched in the embryonic and placental tissues but its expression significantly declines in adult life. In recent years, it has been found that Nectin-4 is especially overexpressed and served as a tumor associated inducer in various malignant tumors including breast, lung, colorectal, pancreatic, ovarian cancers etc. Over-expression of Nectin-4 is associated with various aspects of tumor progression like proliferation, angiogenesis, epithelial to mesenchymal transition, metastasis, DNA repair, tumor relapse, poor prognosis in several types of cancer. This review systematically highlights the implications of Nectin-4 in every possible aspect of cancer and the molecular mechanism of Nectin-4 mediated cancer progression. We have further emphasized on the therapeutic strategies that are being proposed to specifically target Nectin-4.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34547246</pmid><doi>10.1016/j.ejphar.2021.174516</doi><orcidid>https://orcid.org/0000-0003-0297-1030</orcidid><orcidid>https://orcid.org/0000-0003-0687-924X</orcidid><orcidid>https://orcid.org/0000-0001-9015-4473</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0014-2999 |
| ispartof | European journal of pharmacology, 2021-11, Vol.911, p.174516, Article 174516 |
| issn | 0014-2999 1879-0712 1879-0712 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2575370794 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Angiogenesis Animals Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Cancer Cancer stemness Cell Adhesion Molecules - metabolism Humans Metastasis Molecular Targeted Therapy Nectin-4 Nectins Neoplasms - drug therapy Neoplasms - metabolism Neoplasms - pathology Therapeutic strategies |
| title | Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A35%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nectin%20cell%20adhesion%20molecule-4%20(NECTIN-4):%20A%20potential%20target%20for%20cancer%20therapy&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Chatterjee,%20Subhajit&rft.date=2021-11-15&rft.volume=911&rft.spage=174516&rft.pages=174516-&rft.artnum=174516&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/j.ejphar.2021.174516&rft_dat=%3Cproquest_cross%3E2575370794%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2575370794&rft_id=info:pmid/34547246&rft_els_id=S0014299921006701&rfr_iscdi=true |